Emergent cardiac surgery during transcatheter aortic valve implantation (TAVI): insights from the Edwards SAPIEN Aortic Bioprosthesis European Outcome (SOURCE) registry

EuroIntervention 2014;10:975-981 published online ahead of print November 2013. DOI: 10.4244/EIJV10I8A165

Holger Eggebrecht
Holger Eggebrecht1*, MD; Rajendra H. Mehta2, MD, MS; Philipp Kahlert3, MD; Gerhard Schymik4, MD; Thierry Lefèvre5, MD; Rüdiger Lange6, MD; Carlos Macaya7, MD; Lazar Mandinov8, MD; Olaf Wendler9, MD; Martyn Thomas10, MD
1. Cardioangiological Center Bethanien (CCB), Frankfurt, Germany; 2. Duke Clinical Research Institute and Duke University Medical Center, Durham, NC, USA; 3. Department of Cardiology, West German Heart Center Essen, University Duisburg-Essen, Essen, Germa

Aims: Transcatheter aortic valve implantation (TAVI) carries the risk of intraprocedural complications that may ultimately require emergent cardiac surgery (ECS). However, few data exist

Sign in to read and download the full article

Forgot your password?

No account yet?
Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from

aortic valve replacementaortic valve stenosiscomplicationsurgerytavitavr
Read next article
Short-term clinical outcomes among patients undergoing transcatheter aortic valve implantation in Switzerland: the Swiss TAVI registry

Latest news